Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism
Vanessa R. Conde, Pedro F. Oliveira, Ana R. Nunes, et al.
Experimental Cell Research (2015) Vol. 335, Iss. 1, pp. 91-98
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment
Carly C. Barron, Philip J. Bilan, Theodoros Tsakiridis, et al.
Metabolism (2015) Vol. 65, Iss. 2, pp. 124-139
Closed Access | Times Cited: 364
Metabolic phenotype of bladder cancer
Francesco Massari, Chiara Ciccarese, Matteo Santoni, et al.
Cancer Treatment Reviews (2016) Vol. 45, pp. 46-57
Open Access | Times Cited: 247
Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening
Robson Amaral, Mariza Abreu Miranda, Priscyla D. Marcato, et al.
Frontiers in Physiology (2017) Vol. 8
Open Access | Times Cited: 188
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9
Ke-Wang Luo, Wei Chen, Wing-Yin Lung, et al.
The Journal of Nutritional Biochemistry (2016) Vol. 41, pp. 56-64
Closed Access | Times Cited: 125
Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
Julieta Afonso, Lúcio Lara Santos, Adhemar Longatto‐Filho, et al.
Nature Reviews Urology (2020) Vol. 17, Iss. 2, pp. 77-106
Closed Access | Times Cited: 113
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
Nicola Antonio di Meo, Davide Loizzo, Savio Domenico Pandolfo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4173-4173
Open Access | Times Cited: 51
Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems
Daniela Rodrigues, Cármen Jerónimo, Rui Henrique, et al.
International Journal of Cancer (2016) Vol. 139, Iss. 2, pp. 256-268
Open Access | Times Cited: 68
Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis
Keiichiro Mori, Florian Janisch, Hadi Mostafaei, et al.
Urologic Oncology Seminars and Original Investigations (2020) Vol. 38, Iss. 5, pp. 315-333
Closed Access | Times Cited: 52
Recognition of early and late stages of bladder cancer using metabolites and machine learning
Valentina L. Kouznetsova, Elliot Kim, Eden L. Romm, et al.
Metabolomics (2019) Vol. 15, Iss. 7
Closed Access | Times Cited: 54
The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients
Huitao Wang, Kewei Fang, Jinsong Zhang, et al.
International Urology and Nephrology (2017) Vol. 49, Iss. 8, pp. 1391-1398
Closed Access | Times Cited: 49
<p>Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients</p>
Jiayuan Wu, Lin Chen, Yufeng Wang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 5201-5213
Open Access | Times Cited: 48
The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker
Caroline Lo Presti, Florence Fauvelle, Marie‐Christine Jacob, et al.
Blood Advances (2021) Vol. 5, Iss. 1, pp. 156-166
Open Access | Times Cited: 33
Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
Aleksandra Semeniuk-Wojtaś, Karolina Poddębniak-Strama, Magdalena Modzelewska, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 7, pp. 1971-1989
Open Access | Times Cited: 15
The development of plasma pseudotargeted GC-MS metabolic profiling and its application in bladder cancer
Yang Zhou, Ruixiang Song, Zhensheng Zhang, et al.
Analytical and Bioanalytical Chemistry (2016) Vol. 408, Iss. 24, pp. 6741-6749
Closed Access | Times Cited: 46
Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer
Alba Loras, Cristian Suárez-Cabrera, M. Carmen Martínez‐Bisbal, et al.
Cancers (2019) Vol. 11, Iss. 5, pp. 686-686
Open Access | Times Cited: 41
The AST/ALT (De Ritis) Ratio Predicts Survival in Patients with Oral and Oropharyngeal Cancer
Olivia Knittelfelder, Daniela Delago, G. Jakse, et al.
Diagnostics (2020) Vol. 10, Iss. 11, pp. 973-973
Open Access | Times Cited: 38
A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer
Chen Zhang, Xin Gou, Weiyang He, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 32
CDCA3-MYC positive feedback loop promotes bladder cancer progression via ENO1-mediated glycolysis
Dexin Shen, Xiang Yu, Xuefeng Fan, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Metabolic alterations in bladder cancer: applications for cancer imaging
Terry C. Whyard, Wayne C. Waltzer, Douglas Waltzer, et al.
Experimental Cell Research (2016) Vol. 341, Iss. 1, pp. 77-83
Closed Access | Times Cited: 32
Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis
Keiichiro Mori, Noriyoshi Miura, Hadi Mostafaei, et al.
International Journal of Clinical Oncology (2020) Vol. 25, Iss. 8, pp. 1459-1474
Open Access | Times Cited: 28
Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
Daiki Kobayashi, Kazuki Yamamoto, Takeshi Kimura, et al.
Cancer Medicine (2021) Vol. 11, Iss. 3, pp. 798-814
Open Access | Times Cited: 26
CTSV (cathepsin V) promotes bladder cancer progression by increasing NF-κB activity
Yue Xia, Minghuan Ge, Ling Xia, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 10180-10190
Open Access | Times Cited: 18
Transaminase Activity Predicts Survival in Patients with Head and Neck Cancer
Yukinori Takenaka, Norihiko Takemoto, Toshimichi Yasui, et al.
PLoS ONE (2016) Vol. 11, Iss. 10, pp. e0164057-e0164057
Open Access | Times Cited: 28
The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma
Lukas Scheipner, Maria Anna Smolle, Dominik A. Barth, et al.
Anticancer Research (2021) Vol. 41, Iss. 1, pp. 429-436
Open Access | Times Cited: 21
Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway
Jayabal Panneerselvam, Guoxiang Xie, Raymond Che, et al.
Journal of Proteome Research (2016) Vol. 15, Iss. 4, pp. 1333-1341
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top